{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T01:52:58Z","timestamp":1781142778856,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"vor","delay-in-days":1547,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.jfma.2011.09.004","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T11:37:25Z","timestamp":1321270645000},"page":"690-694","source":"Crossref","is-referenced-by-count":5,"title":["A double-masked study to compare the efficacy and safety of topical cromolyn for the treatment of allergic conjunctivitis"],"prefix":"10.1016","volume":"110","author":[{"given":"Yao-lin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fung-Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Jong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2011.09.004_bib1","first-page":"95","article-title":"Differential diagnosis of ocular allergic disorders","volume":"70","author":"Abelson","year":"1993","journal-title":"Ann Allergy"},{"key":"10.1016\/j.jfma.2011.09.004_bib2","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1185\/030079903125001794","article-title":"Topical azelastine in perennial allergic conjunctivitis","volume":"19","author":"Canonica","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jfma.2011.09.004_bib3","series-title":"Immunol immunopathol eye","first-page":"362","article-title":"Histamine in the eye","author":"Abelson","year":"1997"},{"key":"10.1016\/j.jfma.2011.09.004_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1034\/j.1600-0420.2000.078s230018.x","article-title":"Role of histamine in allergic conjunctivitis","volume":"78","author":"Leonardi","year":"2000","journal-title":"Acta\u00a0Ophthalmol Scand"},{"key":"10.1016\/j.jfma.2011.09.004_bib5","first-page":"485","article-title":"Ocular allergy: diagnosis and treatment","volume":"18","author":"Butrus","year":"2005","journal-title":"Ophthalmol Clin North Am"},{"key":"10.1016\/j.jfma.2011.09.004_bib6","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2165\/00003495-197407030-00002","article-title":"Sodium cromoglycate (cromolyn sodium): a review of its mode of action, pharmacology, therapeutic efficacy and use","volume":"7","author":"Brogden","year":"1974","journal-title":"Drug"},{"key":"10.1016\/j.jfma.2011.09.004_bib7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.jaci.2005.01.063","article-title":"The discovery of cromolyn sodium and its effect on research and practice in allergy and immunology","volume":"115","author":"Edwards","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jfma.2011.09.004_bib8","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1136\/bjo.65.5.335","article-title":"Clinical features and diagnosis of adult atopic keratoconjunctivitis and the effect of treatment with sodium cromoglycate","volume":"65","author":"Jay","year":"1981","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfma.2011.09.004_bib9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00003226-199010000-00020","article-title":"Preservatives in ophthalmic topical medications: a significant cause of disease","volume":"9","author":"Olson","year":"1990","journal-title":"Cornea"},{"key":"10.1016\/j.jfma.2011.09.004_bib10","first-page":"361","article-title":"Cytotoxicity of ophthalmic preservatives on human corneal epithelium","volume":"9","author":"Tipathi","year":"1992","journal-title":"Lens Eye Toxic Res"},{"key":"10.1016\/j.jfma.2011.09.004_bib11","first-page":"231","article-title":"Cytotoxicity studies in ophthalmology","volume":"7","author":"Lapalus","year":"1990","journal-title":"Lens Eye Toxic Res"},{"key":"10.1016\/j.jfma.2011.09.004_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/jop.2008.0098","article-title":"Comparative toxicity of preservatives on immortalized corneal and conjunctival epithelial cells","volume":"25","author":"Epstein","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfma.2011.09.004_bib13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1167\/iovs.08-2992","article-title":"Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: early detection of toxic damage","volume":"50","author":"Pauly","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfma.2011.09.004_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1023\/A:1006051725115","article-title":"Adverse effects of topical antiglaucomatous medications on the conjunctiva and lachrymal response","volume":"22","author":"Nuzzi","year":"1998","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfma.2011.09.004_bib15","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1167\/iovs.07-0720","article-title":"A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride","volume":"49","author":"Xiong","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfma.2011.09.004_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.ico.0000116526.57227.82","article-title":"Corneal and conjunctival changes caused by commonly used glaucoma medications","volume":"23","author":"Noecker","year":"2004","journal-title":"Cornea"},{"key":"10.1016\/j.jfma.2011.09.004_bib17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2007.01.036","article-title":"The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways","volume":"115","author":"Baudouin","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfma.2011.09.004_bib18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/jop.2008.0140","article-title":"Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells","volume":"25","author":"Epstein","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jfma.2011.09.004_bib19","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/112067210701700311","article-title":"Ocular symptoms and signs with preserved and preservative-free glaucoma medications","volume":"17","author":"Jaenen","year":"2007","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfma.2011.09.004_bib20","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/bjo.86.4.418","article-title":"Prevalence of ocular symptoms and signs with preserved and preservative-free glaucoma medication","volume":"86","author":"Pisella","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfma.2011.09.004_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1442-9071.2008.01803.x","article-title":"Cytotoxicity of ophthalmic solutions with and without preservatives to human corneal endothelial cells, epithelial cells and conjunctival epithelial cells","volume":"36","author":"Ayaki","year":"2008","journal-title":"Clin Experiment Ophthalmol"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664611000684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664611000684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T10:47:05Z","timestamp":1560941225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664611000684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0929664611000684"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2011.09.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}